Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one-13C3
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Anagrelide 13C3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Anagrelide 13C3 usage and description
Anagrelide 13C3 is a stable isotope-labeled version of Anagrelide, a medication commonly used for the treatment of essential thrombocythemia, a disease characterized by the overproduction of platelets in the blood. Anagrelide is a selective phosphodiesterase III inhibitor that works by reducing the number of platelets produced in the bone marrow. As a result, it helps prevent blood clots and other complications associated with essential thrombocythemia.
The chemical formula of Anagrelide 13C3 is C10H7N3O, and its molecular weight is 181.19 g/mol. It is a white to off-white powder that is soluble in water, ethanol, and methanol. Anagrelide 13C3 is used in clinical and preclinical studies as a tracer compound to study its pharmacokinetic and pharmacodynamic properties in the body.
Anagrelide 13C3 is typically administered orally in the form of a capsule or tablet, with dosages ranging from 0.5 mg to 2.5 mg per day. The medication is known to have several side effects, including headache, dizziness, nausea, and diarrhea. Patients with liver or kidney problems are advised to use Anagrelide with caution, as the medication may worsen their condition.
In conclusion, Anagrelide 13C3 is a stable isotope-labeled version of Anagrelide used in clinical and preclinical studies to study its pharmacokinetic and pharmacodynamic properties. It works by reducing the number of platelets produced in the bone marrow, and is typically administered orally in the form of a capsule or tablet.
